Afghanistan vs Comoros: HIV-positive TB patients on ART (antiretroviral therapy)
Afghanistan
100.0%
in 2024
Comoros
100.0%
in 2023
Afghanistan rank
1st
Comoros rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Afghanistan
- Comoros
How they compare
Afghanistan currently reports 100.0% against 100.0% in Comoros, a difference of 0.0%.
The two have swapped places 2 times across 8 shared years of data; in 2011 it was Comoros ahead.
Afghanistan ranks 1st and Comoros ranks 1st of 144 countries.
Across the 2 decades both report, Afghanistan averaged higher in 1 and Comoros in 1.
Head to head by decade
| Decade | Afghanistan | Comoros | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 71.8% | 100.0% | 28.2% | Comoros |
| 2020s | 100.0% | 91.8% | 8.2% | Afghanistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Afghanistan or Comoros?
- Afghanistan, at 100.0% against 100.0% in Comoros as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Afghanistan and Comoros?
- 0.0%, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Comoros?
- 8 years are reported by both, from 2011 to 2023.
- How do Afghanistan and Comoros rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Afghanistan ranks 1st and Comoros ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.